BSH 2024 - 64th British Society for Haematology Annual Scientific Meeting
Apr 28 - Apr 30, 2024 | LiverpoolUK
LARVOL is not affiliated with 64th British Society for Haematology Annual Scientific Meeting and all trademarks, logos, and brand names are property of their respective owners
Showing 8 titles linked to Trials
ANIMATE: A UK Phase II PET Response-Adapted Trial of Nivolumab in Relapsed Classical Hodgkin Lymphoma
Epcoritamab Monotherapy Leads to Deep and Durable Responses in R/R FL: Pivotal EPCORE NHL-1 Data
Fixed-Duration Glofitamab Monotherapy in Relapsed/Refractory Large B-Cell Lymphoma: Phase II Extended Follow-Up and Subgroup Analyses
Industry Educational Session - Navigating the changing treatment landscape of relapsed refractory DLBCL - Sponsored by Sobi
Avapritinib in patients with advanced systemic mastocytosis (AdvSM): Updated analyses from the PATHFINDER study
Glofitamab Plus R-CHOP or Pola-R-CHP in 1L Diffuse Large B-Cell Lymphoma: a Phase Ib Study
Extended Follow-up of the Phase 3 ALPINE Study of Zanubrutinib Versus Ibrutinib in R/R CLL/SLL
Elranatamab in patients with relapsed or refractory multiple myeloma: updated efficacy and safety from MagnetisMM-3